233 related articles for article (PubMed ID: 20632855)
1. Translational prospects for human induced pluripotent stem cells.
Csete M
Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
[TBL] [Abstract][Full Text] [Related]
2. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.
Carpenter MK; Couture LA
Regen Med; 2010 Jul; 5(4):569-79. PubMed ID: 20632860
[TBL] [Abstract][Full Text] [Related]
3. How induced pluripotent stem cells are redefining personalized medicine.
Ferreira LM; Mostajo-Radji MA
Gene; 2013 May; 520(1):1-6. PubMed ID: 23470844
[TBL] [Abstract][Full Text] [Related]
4. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
Fung RK; Kerridge IH
Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
[TBL] [Abstract][Full Text] [Related]
5. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
Romano G; Morales F; Marino IR; Giordano A
J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
Rowntree RK; McNeish JD
Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
[TBL] [Abstract][Full Text] [Related]
7. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
Grabel L
J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
9. The bioethics of iPS cell-based drug discovery.
Hyun I
Clin Pharmacol Ther; 2011 May; 89(5):646-7. PubMed ID: 21512524
[TBL] [Abstract][Full Text] [Related]
10. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
11. Modeling human neurological disorders with induced pluripotent stem cells.
Imaizumi Y; Okano H
J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
[TBL] [Abstract][Full Text] [Related]
12. Commercialization challenges associated with induced pluripotent stem cell-based products.
Smith D
Regen Med; 2010 Jul; 5(4):593-603. PubMed ID: 20632862
[TBL] [Abstract][Full Text] [Related]
13. Human induced pluripotent stem cells: a review of the US patent landscape.
Georgieva BP; Love JM
Regen Med; 2010 Jul; 5(4):581-91. PubMed ID: 20632861
[TBL] [Abstract][Full Text] [Related]
14. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
15. [Current progress and application prospects of induced pluripotent stem cells].
Qin T; Miao XY
Yi Chuan; 2010 Dec; 32(12):1205-14. PubMed ID: 21513145
[TBL] [Abstract][Full Text] [Related]
16. iPS cell technology in regenerative medicine.
Lengner CJ
Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
[TBL] [Abstract][Full Text] [Related]
17. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of somatic cells.
Rajasingh J
Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
20. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
Nishiyama T; Takeda S
Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
